Tebipenem Pivoxil
Cat.No:IT2300 Solarbio
CAS:161715-24-8
Molecular Formula:C22H31N3O6S2
Molecular Weight:497.63
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Anti-Infection > Anti-Bacterial > Tebipenem PivoxilCAS:161715-24-8
Molecular Formula:C22H31N3O6S2
Molecular Weight:497.63
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 161715-24-8 |
| Name | Tebipenem Pivoxil |
| Molecular Formula | C22H31N3O6S2 |
| Molecular Weight | 497.63 |
| Solubility | Soluble in DMSO ≥10mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| MDL | MFCD17215369 |
| SMILES | CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O |
| InChIKey | SNUDIPVBUUXCDG-QHSBEEBCSA-N |
| InChI | InChI=1S/C22H31N3O6S2/c1-11-15-14(12(2)26)18(27)25(15)16(19(28)30-10-31-20(29)22(3,4)5)17(11)33-13-8-24(9-13)21-23-6-7-32-21/h11-15,26H,6-10H2,1-5H3/t11-,12-,14-,15-/m1/s1 |
| PubChem CID | 9892071 |
| Target Point | Bacterial |
| Passage | Anti-infection |
| Background | It is a carbapenem class of antibiotics. |
| Biological Activity | Tebipenem pivoxil 是一种新型口服的 Carbapenem抗生素,用于治疗鼻咽喉及呼吸道感染。[1] |
| Data Literature Source | [1]. Kato K,et al. Intestinal absorption mechanism of tebipenem pivoxil,a novel oral carbapenem: involvement of human OATP family in apical membrane transport. Mol Pharm. 2010 Oct 4;7(5):1747-56. [2]. Kijima K,et al. [Pharmacokinetics of tebipenem pivoxil,a novel oral carbapenem antibiotic,in experimental animals]. Jpn J Antibiot. 2009 Jun;62(3):214-40. [3]. Kobayashi R,et al. In vitro activity of tebipenem,a new oral carbapenem antibiotic,against penicillin-nonsusceptible Streptococcus pneumoniae. Antimicrob Agents Chemother. 2005 Mar;49(3):889-94. [4]. Muratani T,et al. [Antimicrobial activity of tebipenem against various clinical isolates from various specimen,mainly urinary tract]. Jpn J Antibiot. 2009 Apr;62(2):116-26. [5]. Hotomi M,et al. Efficacy of a novel oral carbapenem,tebipenem pivoxil (TBM-PI),against experimental otitis media caused by penicillin resistant Streptococcus pneumoniae in chinchilla. Vaccine. 2007 Mar 22;25(13):2478-84. |
| Unit | Bottle |
| Specification | 5mg 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download